X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
folfirinox (516) 516
pancreatic cancer (380) 380
gemcitabine (337) 337
index medicus (322) 322
chemotherapy (298) 298
oncology (282) 282
humans (252) 252
cancer (233) 233
adenocarcinoma (211) 211
survival (211) 211
female (161) 161
male (161) 161
pancreatic neoplasms - drug therapy (159) 159
aged (153) 153
middle aged (144) 144
pancreatic neoplasms - pathology (137) 137
metastasis (129) 129
surgery (129) 129
antineoplastic combined chemotherapy protocols - therapeutic use (121) 121
nab-paclitaxel (111) 111
therapy (104) 104
treatment outcome (103) 103
gastroenterology & hepatology (94) 94
neoadjuvant therapy (90) 90
adult (88) 88
care and treatment (88) 88
deoxycytidine - analogs & derivatives (79) 79
retrospective studies (74) 74
patients (71) 71
analysis (70) 70
oxaliplatin (70) 70
pancreatic neoplasms - mortality (70) 70
resection (70) 70
phase-iii trial (68) 68
prognosis (68) 68
adenocarcinoma - drug therapy (66) 66
medicine & public health (65) 65
cancer therapies (64) 64
trial (63) 63
camptothecin - analogs & derivatives (62) 62
fluorouracil - administration & dosage (62) 62
chemoradiotherapy (60) 60
pancreatic neoplasms - surgery (57) 57
irinotecan (56) 56
neoplasm staging (55) 55
aged, 80 and over (54) 54
deoxycytidine - administration & dosage (54) 54
leucovorin - administration & dosage (53) 53
ductal adenocarcinoma (52) 52
camptothecin - administration & dosage (51) 51
medical prognosis (51) 51
organoplatinum compounds - administration & dosage (51) 51
pancreatic neoplasms - therapy (51) 51
antineoplastic combined chemotherapy protocols - adverse effects (50) 50
usage (50) 50
adenocarcinoma - pathology (45) 45
disease-free survival (45) 45
research (45) 45
carcinoma (44) 44
chemoradiation (43) 43
clinical trials (43) 43
survival rate (43) 43
health aspects (41) 41
radiotherapy (41) 41
pharmacology & pharmacy (40) 40
pancreatic adenocarcinoma (39) 39
pancreaticoduodenectomy (39) 39
tumors (39) 39
drug therapy (38) 38
outcomes (38) 38
paclitaxel plus gemcitabine (38) 38
toxicity (38) 38
adjuvant chemotherapy (37) 37
pancreatectomy (37) 37
5-fluorouracil (36) 36
kaplan-meier estimate (36) 36
antineoplastic combined chemotherapy protocols - administration & dosage (35) 35
metastases (35) 35
patient outcomes (35) 35
phase-ii (35) 35
survival analysis (35) 35
abridged index medicus (34) 34
adenocarcinoma - surgery (34) 34
fluorouracil (34) 34
deoxycytidine - therapeutic use (33) 33
neoplasm metastasis (33) 33
adenocarcinoma - mortality (32) 32
adjuvant treatment (32) 32
folinic acid (32) 32
pancreatic ductal adenocarcinoma (32) 32
antineoplastic agents - therapeutic use (31) 31
carcinoma, pancreatic ductal - drug therapy (31) 31
medical research (31) 31
metastatic pancreatic cancer (31) 31
neoplasms. tumors. oncology. including cancer and carcinogens (31) 31
mortality (30) 30
carcinoma, pancreatic ductal - pathology (29) 29
efficacy (29) 29
plus gemcitabine (29) 29
locally advanced pancreatic cancer (28) 28
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (542) 542
German (13) 13
Japanese (6) 6
French (5) 5
Czech (2) 2
Chinese (1) 1
Italian (1) 1
Korean (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Oncology, ISSN 0030-2414, 08/2011, Volume 80, Issue 5-6, pp. 301 - 306
Journal Article
Journal Article
Drugs in Context, ISSN 1745-1981, 12/2012, Volume 2012, pp. 212244 - 4
Pancreatic cancer is an incredibly challenging disease due to its high rates of resistance to traditional chemotherapy and radiotherapy. There has been little... 
Oncolytic viruses | FOLFIRINOX | Gemcitabine | Carbon nanotubes | siRNA | EGFR | p21 | p53 | Nanoparticles | MUC1 | Erlotinib | p16 | shRNA | Pancreatic cancer | Mesothelin | Monoclonal antibodies | VEGFR | KRAS | Liposomes | Suicide genes | liposomes | erlotinib | mesothelin | pancreatic cancer | nanoparticles | carbon nanotubes | gemcitabine | oncolytic viruses | monoclonal antibodies | suicide genes
Journal Article
9/2012, Volume 4, Issue 5, 9
Pancreatic cancer has historically proven resistant to anticancer agents. On the one hand, drugs might be more efficient if higher levels could be achieved at... 
pancreatic cancer | gemcitabine | drug delivery | folfirinox | chemotherapy | resistance | CELLS | CURCUMIN | ADENOCARCINOMA | TUMORS | IN-VITRO | INHIBITION | ONCOLOGY | ALBUMIN-BOUND PACLITAXEL | TARGETED DELIVERY | BLOOD | Reviews
Book Review
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 3/2012, Volume 69, Issue 3, pp. 807 - 814
Biweekly schedule of capecitabine combined with irinotecan (XELIRI), consecutively with irinotecan and oxaliplatin (XELIRINOX), was evaluated in patients with... 
Irinotecan | Biweekly | Medicine & Public Health | Capecitabine | Recommended dose | Cancer Research | Oncology | Oxaliplatine | Pharmacology/Toxicology | Metastatic colorectal cancer | 2 DIFFERENT SCHEDULES | 1ST-LINE TREATMENT | METABOLITES | FOLFIRINOX | EFFICACY | FLUOROURACIL PLUS LEUCOVORIN | TOXICITY | ADVANCED COLORECTAL-CANCER | ORAL CAPECITABINE | PHARMACOKINETICS | ONCOLOGY | PHARMACOLOGY & PHARMACY | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prospective Studies | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - pharmacokinetics | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Chromatography, High Pressure Liquid | Feasibility Studies | Dose-Response Relationship, Drug | Fluorouracil - therapeutic use | Glucuronosyltransferase - genetics | Deoxycytidine - pharmacokinetics | Deoxycytidine - therapeutic use | Neoplasm Metastasis | Organoplatinum Compounds - administration & dosage | Fluorouracil - administration & dosage | Fluorouracil - adverse effects | Neoplasms - genetics | Organoplatinum Compounds - pharmacokinetics | Adult | Camptothecin - administration & dosage | Deoxycytidine - adverse effects | Female | Camptothecin - analogs & derivatives | Camptothecin - pharmacokinetics | Camptothecin - adverse effects | Camptothecin - therapeutic use | Drug Administration Schedule | Fluorouracil - analogs & derivatives | Deoxycytidine - administration & dosage | Neoplasms - drug therapy | Maximum Tolerated Dose | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Mutation | Fluorouracil - pharmacokinetics | Neoplasms - pathology | Organoplatinum Compounds - therapeutic use | Deoxycytidine - analogs & derivatives | Organoplatinum Compounds - adverse effects | Care and treatment | Colorectal cancer | Diarrhea | Clinical trials | Product development | Metastasis | Drug therapy, Combination | Cancer | Index Medicus
Journal Article
PLoS ONE, ISSN 1932-6203, 11/2013, Volume 8, Issue 11, p. e78225
Journal Article
Chemotherapy, ISSN 0009-3157, 02/2014, Volume 59, Issue 4, pp. 273 - 279
Journal Article